Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

A clinical trial led by the National Cancer Institute (NCI), part of the National Institutes of Health, has resulted in the first approval of...

The FDA has approved atezolizumab (Tecentriq) for adult and pediatric patients aged 2 years and older with unresectable or metastatic alveolar soft part...

The FDA has approved atezolizumab (Tecentriq) for adult and pediatric patients aged 2 years and older with unresectable or metastatic alveolar soft part...

Dr Millie Das, MD opens a discussion surrounding updates regarding non-small cell lung cancer (NSCLC) as presented at the 2022 World Conference on Lung...

Atezolizumab has been granted FDA approval for patients aged 2 years and older with unresectable or metastatic alveolar soft part...

Stephen V. Liu, MD, discusses the effect of the FDA approval of atezolizumab on the development of other chemoimmunotherapy regimens and ongoing efforts to...

Atezolizumab administered before and during chemoradiation appeared safe and demonstrated immune-modulating activity among women with node-positive locally advanced cervical cancer, according to study results....

  • 1617492409235144706 Profile photo of Madelyn

    #CervicalCancerAwarenessMonth Atezolizumab administered before and during chemoradiation appeared safe and demonstrated immune-modulating activity. https://t.co/nPu4LdfILk #Tecentriq @genentech #womenshealth #Atezolizumab #CervicalCancer #Cancer #HemOnc #OncAlert #MedEd - view on twitter